维普中文期刊产品整合服务
120篇 您的检索式:作者名="Wickerham"
    题名 作者 年代 出处 被引量
1Association of tamoxifen and uterine sarcoma显示文摘Wickerham DL Fisher B Wolmark N 2002Clin Oncol2002,20,11:1
2Tamoxifen's impact as a preventive agent in clinical practice and an update on the STAR trial显示文摘Wickerham DL 2003Recent Results Cancer Res2003,163,1:1
3Effects of tamox- ifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial 显示文摘Vogel VG Costantino JP Wickerham DL 2006JAMA2006,295,23:1
4Tamoxifen for the prevention of breast cancer: current status of the national surgical adjuvant breast and bowel project P-1 study 显示文摘Fisher B Costantino JP Wickerham DL 2005J Natl Cancer Inst2005,97,22:1
5Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes显示文摘Vogel VG Costantino JP Wickerham DL 0,,:1
6Effects of tamoxifen vs raloxifene on the risk of developing invasivebreast cancer and disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial显示文摘Vogel VG Costantino JP Wickerham DL 2006JAMA2006,295,23:1
7Prevention of hormonerelated cancers:breast cancer显示文摘Dunn BK Wickerham DL Ford LG 2005J Clin Oncol2005,23,2:1
8Doxorubicin containing regimens for the treatment of stage II breast cancer: The Na- tional Surgical Adjuvant Breast and Bowel Project experience显示文摘Fisher B Redmond C Wickerham DL 1989J Clin Oncol1989,7,:1
9Tamoxifen for the prevention of breast cancer:current status of the national surgical adjuvant breast and bowel project P-1 study 显示文摘Fisher B Costantino JP Wickerham DL 2005J Natl Cancer Inst2005,97,22:1
10Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen : Inten- tion-to-treat analysis of the National Surgical Adjuvant Breast and Bowel Project B -33 trial 显示文摘Mamounas EP Jeong JH Wickerham D 2008J Clin Oncol2008,26,12:1
11Tamoxifen for prevention of breast cancer:report of the national surgical adjuvant breast and bowel project P-1 sutdy显示文摘 Costantino JP Wickerham DL etal 1998J Natl Cancer Inst1998,90,18:1
12Tamoxifen for prevention ofbreast cancer: report of the National Surgical AdjuvantBreast and Bowel Project P2I Study显示文摘Fisher B Costantino JP Wickerham DL 1998J Natl Cancer Inst1998,90,18:1
13Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study显示文摘Fisher B Costantino J P Wickerham D L 1998J Natl Cancer Inst1998,90,18:1
14Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen:intention to-treat analysis of the national surgical adjuvant breast and bowel project B-33 trial 显示文摘Mamounas EP Jeong JH Wickerham DL 2008J Clin 0ncol2008,26,12:1
15Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study显示文摘Fisher B Costantino JP Wickerham DL 1998J Natl Cancer Inst1998,90,18:1
16Tmnoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study显示文摘Fisher B Costantino J P Wickerham D L 1998J Natl Cancer Inst1998,90,:1
17Tamoxifen for the prevention of breast cancer:current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study显示文摘Fisher B Costantino J P Wickerham D L 2005J Natl Cancer Inst2005,97,22:1
18Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial显示文摘Chalas E Costantino JP Wickerham DL 2005Am J Obstet Gynecol2005,192,4:1
19Tamoxifen for prevention of breast cancer:report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study显示文摘FISHER B COSTANTINO J P WICKERHAM D L et a1 1998J Nat Can Ins1998,90,18:1
20Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes:the NSABP Study of Tamoxifen and Raloxifene(STAR)P-2trial显示文摘 Costantino JP Wickerham DL 2006JAMA2006,295,23:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费